Ruediger Spitz

917 total citations
12 papers, 651 citations indexed

About

Ruediger Spitz is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ruediger Spitz has authored 12 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 9 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Ruediger Spitz's work include Neuroblastoma Research and Treatments (11 papers), Cancer therapeutics and mechanisms (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Ruediger Spitz is often cited by papers focused on Neuroblastoma Research and Treatments (11 papers), Cancer therapeutics and mechanisms (6 papers) and Neuroendocrine Tumor Research Advances (4 papers). Ruediger Spitz collaborates with scholars based in Germany, Switzerland and United Kingdom. Ruediger Spitz's co-authors include Frank Berthold, Barbara Hero, Karen Ernestus, Thorsten Simon, Freimut H. Schilling, G. Benz-Bohm, Astrid Gnekow, Dirk Schwabe, Manfred Schwab and André Oberthuer and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Ruediger Spitz

12 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruediger Spitz Germany 11 594 335 262 154 111 12 651
W. B. London United States 6 423 0.7× 233 0.7× 232 0.9× 120 0.8× 51 0.5× 17 492
Garrett M. Brodeur United States 7 346 0.6× 284 0.8× 156 0.6× 97 0.6× 73 0.7× 8 506
Hiroaki Yamaoka Japan 13 189 0.3× 298 0.9× 118 0.5× 74 0.5× 30 0.3× 24 479
Lee McDaniel United States 8 234 0.4× 244 0.7× 202 0.8× 117 0.8× 42 0.4× 12 438
S J Yeh United States 5 296 0.5× 170 0.5× 69 0.3× 119 0.8× 44 0.4× 7 383
Joshua Courtright United States 4 192 0.3× 237 0.7× 128 0.5× 123 0.8× 17 0.2× 6 380
A Zellner Austria 5 178 0.3× 113 0.3× 73 0.3× 59 0.4× 27 0.2× 5 313
Sira Moreno Spain 9 68 0.1× 158 0.5× 101 0.4× 46 0.3× 61 0.5× 17 350
Ricky M. Trigg United Kingdom 9 132 0.2× 169 0.5× 195 0.7× 126 0.8× 25 0.2× 11 333
Nai‐Kong V. Cheung United States 8 198 0.3× 147 0.4× 41 0.2× 97 0.6× 26 0.2× 8 326

Countries citing papers authored by Ruediger Spitz

Since Specialization
Citations

This map shows the geographic impact of Ruediger Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Spitz more than expected).

Fields of papers citing papers by Ruediger Spitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruediger Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Spitz. The network helps show where Ruediger Spitz may publish in the future.

Co-authorship network of co-authors of Ruediger Spitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ruediger Spitz. A scholar is included among the top collaborators of Ruediger Spitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruediger Spitz. Ruediger Spitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Theißen, Jessica, André Oberthuer, Ruth Volland, et al.. (2014). Chromosome 17/17q gain and unaltered profiles in high resolution array‐CGH are prognostically informative in neuroblastoma. Genes Chromosomes and Cancer. 53(8). 639–649. 27 indexed citations
2.
Theißen, Jessica, Ruediger Spitz, David R. Betts, et al.. (2009). Heterogeneity of the MYCN Oncogene in Neuroblastoma. Clinical Cancer Research. 15(6). 2085–2090. 37 indexed citations
3.
Hero, Barbara, Thorsten Simon, Ruediger Spitz, et al.. (2008). Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97. Journal of Clinical Oncology. 26(9). 1504–1510. 191 indexed citations
4.
Spitz, Ruediger, André Oberthuer, Marc Zapatka, et al.. (2006). Oligonucleotide array‐based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome. Genes Chromosomes and Cancer. 45(12). 1130–1142. 64 indexed citations
5.
Spitz, Ruediger, David R. Betts, Thorsten Simon, et al.. (2006). Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma. Cancer Genetics and Cytogenetics. 167(1). 51–56. 26 indexed citations
6.
Spitz, Ruediger, Barbara Hero, Thorsten Simon, & Frank Berthold. (2006). Loss in Chromosome 11q Identifies Tumors with Increased Risk for Metastatic Relapses in Localized and 4S Neuroblastoma. Clinical Cancer Research. 12(11). 3368–3373. 69 indexed citations
7.
Fischer, Matthias, et al.. (2005). Quantitative Real-Time PCR for Quick Simultaneous Determination of Therapy-Stratifying Markers MYCN Amplification, Deletion 1p and 11q. Diagnostic Molecular Pathology. 14(3). 177–182. 6 indexed citations
8.
Spitz, Ruediger, et al.. (2004). MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. European Journal of Cancer. 40(18). 2753–2759. 44 indexed citations
9.
Spitz, Ruediger, Barbara Hero, Karen Ernestus, & Frank Berthold. (2003). FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high‐risk groups in neuroblastoma. Medical and Pediatric Oncology. 41(1). 30–35. 35 indexed citations
10.
Spitz, Ruediger, Barbara Hero, Karen Ernestus, & Frank Berthold. (2003). Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.. PubMed. 9(1). 52–8. 95 indexed citations
11.
Spitz, Ruediger, Barbara Hero, Karen Ernestus, & Frank Berthold. (2003). Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.. PubMed. 9(13). 4835–40. 26 indexed citations
12.
Spitz, Ruediger, Barbara Hero, Frank Westermann, et al.. (2002). Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes and Cancer. 34(3). 299–305. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. B. London Breakdown of academic impact, for papers by Garrett M. Brodeur Breakdown of academic impact, for papers by Hiroaki Yamaoka Breakdown of academic impact, for papers by Lee McDaniel Breakdown of academic impact, for papers by S J Yeh Breakdown of academic impact, for papers by Joshua Courtright Breakdown of academic impact, for papers by A Zellner Breakdown of academic impact, for papers by Sira Moreno Breakdown of academic impact, for papers by Ricky M. Trigg Breakdown of academic impact, for papers by Nai‐Kong V. Cheung
Rankless by CCL
2026